ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1442

$547K Total Retail Price of All Prescriptions

Rank: 92 out of 1442

509 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 16,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$31 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 2,022 1,926 1 2
LOSARTAN POTASSIUM 1,254 1,190 2 13
ATENOLOL 939 895 3 11
ALENDRONATE SODIUM 637 623 4 46
ENALAPRIL MALEATE 518 485 5 23
METFORMIN HCL ER 504 471 6 71
NIFEDIPINE ER 502 490 7 39
URSODIOL 466 463 10 8 173
EXFORGE 457 455 10 9 80
AMLODIPINE BESYLATE 431 419 10 3
GLIPIZIDE XL 407 405 11 107
WARFARIN SODIUM 403 376 12 9
ALLOPURINOL 372 368 13 47
DIGOXIN 365 365 14 15
OMEPRAZOLE 309 284 15 21
AMOXICILLIN 251 235 16 129
DOXAZOSIN MESYLATE 247 247 17 69
METOPROLOL TARTRATE 246 233 18 6
FUROSEMIDE 241 239 19 5
TAMSULOSIN HCL 230 219 20 38
LEVOTHYROXINE SODIUM 214 209 21 22
FINASTERIDE 210 210 22 87
GLIPIZIDE ER 208 190 23 161
METFORMIN HCL 190 185 24 26
CLOPIDOGREL 177 176 25 12
THEOPHYLLINE ANHYDROUS 170 166 26 231
AVODART 164 160 27 145
ACARBOSE 158 152 28 155
PLAVIX 154 154 29 14
AZITHROMYCIN 152 144 30 56
RANITIDINE HCL 143 132 31 64
CARVEDILOL 140 135 32 8
CLOBETASOL PROPIONATE 126 122 33 190
LANTUS SOLOSTAR 123 118 34 147
LANTUS 114 107 35 139
MECLIZINE HCL 113 106 36 83
ALBUTEROL SULFATE 110 110 37 125
ZOLPIDEM TARTRATE 109 86 38 25
ADVAIR DISKUS 104 104 39 79
LIDOCAINE 99 99 40 152
BENZTROPINE MESYLATE 98 73 R 41 206
DIOVAN 90 90 42 19
CIPROFLOXACIN HCL 81 77 43 103
NIFEDICAL XL 80 61 44 140
DONEPEZIL HCL 73 73 45 62
AMLODIPINE BESYLATE-BENAZEPRIL 71 68 46 43
HYDROCORTISONE VALERATE 68 63 47 185
AMOX TR-POTASSIUM CLAVULANATE 68 65 47 166
GABAPENTIN 67 67 49 55
VENTOLIN HFA 64 63 50 175
JANUVIA 63 52 51 45
AMMONIUM LACTATE 61 60 52 156
FLUTICASONE PROPIONATE 58 50 53 99
CLONIDINE HCL 57 57 54 66
UNIFINE PENTIPS 56 54 55 340
INSULIN SYRINGE 56 46 55 238
EVISTA 56 56 55 73
CLOTRIMAZOLE 54 32 58 346
PROAIR HFA 54 54 58 123
HYDROCHLOROTHIAZIDE 52 52 60 16
SINGULAIR 52 52 60 93
NEXIUM 51 47 62 34
CLOTRIMAZOLE-BETAMETHASONE 51 43 62 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.